Skip to content

Therapeutic Hypothermia for birth Asphyxia using Revive servo-controlled device â?? a randomised controlled trial.

Therapeutic hypothermia for birth Asphyxia using a new servo-controlled device â?? A randomised controlled trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025902
Enrollment
50
Registered
2020-06-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P916- Hypoxic ischemic encephalopathy [HIE]

Interventions

Intervention1: Servo-controlled Whole Body Cooling: This device will automatically perform whole body cooling non-invasively by monitoring the core body temperature of the baby using rectal means. Con

Sponsors

Sensivision Health Technologies Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i. Inborn baby with GA >= 36 weeks and BW >= 2000 grams ii. Age less than 6 hours iii. Umbilical arterial (or gas within 1 hour of life) pH = 12 meq/L. If blood gas is unavailable, then any one of the following can be used a) APGAR b) Assisted ventilation for at least 10 min after birth c) History of acute perinatal event- intrapartum fetal distress, cord prolapse, placental abruption, maternal trauma, uterine rupture, cardiac arrest iv. Presence of moderate or severe encephalopathy by clinical examination (Modified Sarnat & Sarnat staging) consisting of: a) Seizures b) Altered state of consciousness (reduced or absent response to stimulation) c) Abnormal tone (focal or general hypotonia, or flaccid) d) Abnormal primitive reflexes (weak or absent suck or Moro response)

Exclusion criteria

Exclusion criteria: 1) Major congenital abnormalities 2) Babies who fail to establish spontaneous respiration at 20 minutes of life 3) Absent heart rate at 10 min of age despite adequate resuscitation 4) Risk of imminent death

Design outcomes

Primary

MeasureTime frame
Effective cooling time (increased cooling effectiveness through effectively maintaining the the rectal temperature within the target temperature range of 33°C to 34°C during the maintenance.)Timepoint: Continuous rectal temperature monitoring until 90 hours of age, and then every 8 h for the first week after birth.

Secondary

MeasureTime frame
- Time to induction of cooling - Mortality from any cause before discharge from hospital - Gastric bleeds - Persistent hypotension - Pulmonary haemorrhage - Persistent pulmonary hypertension - Bleeding diathesis requiring blood products - Culture-proven early onset sepsis - Necrotizing enterocolitis - Cardiac arrhythmia requiring therapy - Severe thrombocytopenia (25,000/mm3) - Renal failure (anuria 48 h with azotemia) - Subcutaneous fat necrosisTimepoint: Before discharge from hospital

Countries

India

Contacts

Public ContactDr G Guruprasad

J.J.M Medical College

dr_g_gp@yahoo.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026